𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pre-emptive therapy with rituximab for prevention of Epstein–Barr virus-associated lymphoproliferative disease after hematopoietic stem cell transplantation

✍ Scribed by Gruhn, B; Meerbach, A; Häfer, R; Zell, R; Wutzler, P; Zintl, F


Book ID
110013746
Publisher
Nature Publishing Group
Year
2003
Tongue
English
Weight
105 KB
Volume
31
Category
Article
ISSN
0007-1188

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Monitoring of Epstein-Barr virus load af
✍ Astrid Meerbach; Peter Wutzler; Ralf Häfer; Felix Zintl; Bernd Gruhn 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

## Abstract Epstein‐Barr virus (EBV)‐associated post‐transplant lymphoproliferative disease is a life‐threatening complication following hematopoietic stem cell transplantation. A quantitative polymerase chain reaction to evaluate EBV‐genome copy numbers based on a nested polymerase chain reaction